24 November 2024 false No description of principal activity Taxfiler 2024.6 16098976business:PrivateLimitedCompanyLtd2024-11-242025-11-30 160989762024-11-23 160989762024-11-242025-11-30 16098976business:AuditExempt-NoAccountantsReport2024-11-242025-11-30 16098976business:FilletedAccounts2024-11-242025-11-30 160989762025-11-30 16098976business:Director12024-11-242025-11-30 16098976business:RegisteredOffice2024-11-242025-11-30 16098976core:WithinOneYear2025-11-30 16098976core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-11-30 16098976core:PreviouslyStatedAmount2025-11-30 16098976business:SmallEntities2024-11-242025-11-30 16098976countries:EnglandWales2024-11-242025-11-30 16098976core:AfterOneYear2025-11-30 iso4217:GBP xbrli:pure
Company Registration No. 16098976 (England and Wales)
Mirla Health Ltd Unaudited accounts for the period from 24 November 2024 to 30 November 2025
Mirla Health Ltd Unaudited accounts Contents
Page
- 2 -
Mirla Health Ltd Company Information for the period from 24 November 2024 to 30 November 2025
Director
Erica E OPARE-SAKYI
Company Number
16098976 (England and Wales)
Registered Office
20 Wenlock Road London N1 7GU England
Accountants
Riverview Accounting Building 56 Cubaroo Cirrus Way Humber Enterprise Park Brough East Yorkshire HU15 1XW
- 3 -
Mirla Health Ltd Statement of financial position as at 30 November 2025
2025 
Notes
£ 
Current assets
Debtors
21,332 
Cash at bank and in hand
7 
21,339 
Creditors: amounts falling due within one year
(3,994)
Net current assets
17,345 
Net assets
17,345 
Capital and reserves
Profit and loss account
17,345 
Shareholders' funds
17,345 
For the period ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 20 August 2026 and were signed on its behalf by
Erica E OPARE-SAKYI Director Company Registration No. 16098976
- 4 -
Mirla Health Ltd Notes to the Accounts for the period from 24 November 2024 to 30 November 2025
1
Statutory information
Mirla Health Ltd is a private company, limited by shares, registered in England and Wales, registration number 16098976. The registered office is 20 Wenlock Road, London, N1 7GU, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Debtors
2025 
£ 
Amounts falling due after more than one year
Other debtors
21,332 
5
Creditors: amounts falling due within one year
2025 
£ 
Taxes and social security
3,994 
6
Average number of employees
During the period the average number of employees was 0.
- 5 -